Variations in IL-1R1 Gene Influence Risk for Hepatitis B Virus Infection of Children in a Han Chinese population

International Journal of Infectious Diseases

Volumn 55, Issue , 2017, Pages 45-50

  Fan, Jie ^a   Cai, Yiling ^b   Huang, Xin ^a   Wang, Yan ^a   Mu, Lihong ^a   Zhou, Li ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

breakthrough infection; children; HBV; single nucleotide polymorphism

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 1BETA; HEPATITIS B ANTIBODY; INTERLEUKIN 1 RECEPTOR TYPE I;

ALLELE; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIATION; GENOTYPE; HAN CHINESE; HEPATITIS B; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; EPIDEMIC; GENETIC PREDISPOSITION; GENETICS; HEALTH SURVEY; HEPATITIS B VIRUS; IMMUNOLOGY; PRESCHOOL CHILD;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD, PRESCHOOL; CHINA; DISEASE OUTBREAKS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INFANT; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION SURVEILLANCE; RECEPTORS, INTERLEUKIN-1 TYPE I;

EID: 85009964375     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2016.12.021     Document Type: Article

References (22)

1. 1 Liaw, Y.F., Chu, C.M., Hepatitis B virus infection. Lancet 373 (2009), 582–592.
2. 2 Komatsu, H., Inui, A., Hepatitis B virus infection in children. Expert Rev Anti Infect Ther 13 (2015), 427–450.
3. 3 Gusatti, C.S., Costi, C., de Medeiros, R.M., Halon, M.L., Grandi, T., Medeiros, A.F., et al. Association between cytokine gene polymorphisms and outcome of hepatitis B virus infection in southern Brazil. J Med Virol, 2016.
4. 4 Ni, Y.H., Chen, D.S., Hepatitis B vaccination in children the Taiwan experience. Pathol Biol (Paris) 58 (2010), 296–300.
5. 5 Li, F., Wang, Q., Zhang, L., Su, H., Zhang, J., Wang, T., et al. The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest China. Vaccine 30 (2012), 7118–7122.
6. 6 Wang, Y., Xu, P., Zhu, D., Zhang, S., Bi, Y., Hu, Y., et al. Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life. Vaccine 30 (2012), 5708–5713.
7. 7 Ding, Y., Sheng, Q., Ma, L., Dou, X., Chronic HBV infection among pregnant women and their infants in Shenyang, China. Virol J, 10, 2013, 17.
8. 8 Liang, X., Bi, S., Yang, W., Wang, L., Cui, G., Cui, F., et al. Reprint of: Epidemiological serosurvey of Hepatitis B in China?declining HBV prevalence due to Hepatitis B vaccination. Vaccine 31:Suppl 9 (2013), J21–J28.
9. 9 Cui, F., Luo, H., Wang, F., Zheng, H., Gong, X., Chen, Y., et al. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation. Vaccine 31:Suppl 9 (2013), J36–42.
10. 10 Xu, Z.Y., Duan, S.C., Margolis, H.S., Purcell, R.H., Ou-Yang, P.Y., Coleman, P.J., et al. Long-term efficacy of active postexposure immunization of infants for prevention of hepatitis B virus infection. United States-People's Republic of China Study Group on Hepatitis B. J Infect Dis 171 (1995), 54–60.
11. 11 Zeng, Z., Human genes involved in hepatitis B virus infection. World J Gastroenterol 20 (2014), 7696–7706.
12. 12 Biswas, A., Panigrahi, R., Pal, M., De, B.K., Chakrabarti, S., Ghosh, M.K., et al. Association of Interleukin-1beta and Gene Polymorphisms with Liver Pathogenesis in Hepatitis B Virus Infection among Eastern Indian Population. J Clin Exp Hepatol 3 (2013), 281–287.
13. 13 Palomo, J., Dietrich, D., Martin, P., Palmer, G., Gabay, C., The interleukin (IL)-1 cytokine family—Balance between agonists and antagonists in inflammatory diseases. Cytokine 76 (2015), 25–37.
14. 14 Zhang, P.A., Wu, J.M., Li, Y., Yang, X.S., Association of polymorphisms of interleukin-18 gene promoter region with chronic hepatitis B in Chinese Han population. World J Gastroenterol 11 (2005), 1594–1598.
15. 15 Ryckman, K.K., Fielding, K., Hill, A.V., Mendy, M., Rayco-Solon, P., Sirugo, G., et al. Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis. PLoS One, 5, 2010, e12273.
16. 16 Li, C., Ji, H., Cai, Y., Ayana, D.A., Lv, P., Liu, M., et al. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment. J Interferon Cytokine Res 33 (2013), 612–618.
17. 17 Ferreira, S.C., Chacha, S.G., Souza, F.F., Teixeira, A.C., Santana, R.C., Deghaide, N.H., et al. IL-18, TNF, and IFN-gamma alleles and genotypes are associated with susceptibility to chronic hepatitis B infection and severity of liver injury. J Med Virol 87 (2015), 1689–1696.
18. 18 Saxena, R., Chawla, Y.K., Verma, I., Kaur, J., Interleukin-1 polymorphism and expression in hepatitis B virus-mediated disease outcome in India. J Interferon Cytokine Res 33 (2013), 80–89.
19. 19 Park, S.W., Kim, M.K., Kwon, K.H., Kim, J., Association between a promoter polymorphism (rs2192752, −1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population. Int J Immunogenet 39 (2012), 501–507.
20. 20 He, D., Tao, S., Guo, S., Li, M., Wu, J., Huang, H., et al. Interaction of TLR-IFN and HLA polymorphisms on susceptibility of chronic HBV infection in Southwest Han Chinese. Liver Int 35 (2015), 1941–1949.
21. 21 Shao, Z.J., Zhang, L., Xu, J.Q., Xu, D.Z., Men, K., Zhang, J.X., et al. Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J Med Virol 83 (2011), 791–795.
22. 22 Yucesoy, B., Talzhanov, Y., Johnson, V.J., Wilson, N.W., Biagini, R.E., Wang, W., et al. Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations. Vaccine 31 (2013), 5381–5391.